Lakewood Capital Management, LP Charles River Laboratories International, Inc. Transaction History

Lakewood Capital Management, LP

$1.06 Billion
Q1 2025

A detailed history of Lakewood Capital Management, LP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Lakewood Capital Management, LP holds 140,240 shares of CRL stock, worth $19.2 Million. This represents 1.99% of its overall portfolio holdings.

Number of Shares

140,240

Previous 111,740 25.51%

Holding current value

$19.2 Million

Previous $20.6 Million 2.33%

% of portfolio

1.99%

Previous 2.08%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$150.52 - $190.14 $4.29 Million - $5.42 Million	28,500 Added 25.51%	140,240 $21.1 Million
Q2 2024 Aug 14, 2024	SELL	$206.39 - $268.73 $206,390 - $268,730	-1,000 Reduced 0.89%	111,740 $23.1 Million
Q1 2024 May 15, 2024	SELL	$203.52 - $273.43 $1.02 Million - $1.37 Million	-5,000 Reduced 4.25%	112,740 $30.5 Million
Q4 2023 Feb 14, 2024	BUY	$164.52 - $238.84 $4.94 Million - $7.17 Million	30,000 Added 34.19%	117,740 $27.8 Million
Q4 2022 Feb 14, 2023	SELL	$197.11 - $250.07 $3.55 Million - $4.5 Million	-18,000 Reduced 17.02%	87,740 $19.1 Million
Q3 2022 Nov 14, 2022	SELL	$182.44 - $250.54 $7.12 Million - $9.77 Million	-39,000 Reduced 26.94%	105,740 $20.8 Million
Q2 2022 Aug 15, 2022	BUY	$204.13 - $302.4 $13.8 Million - $20.5 Million	67,640 Added 87.73%	144,740 $31 Million
Q1 2022 May 16, 2022	BUY	$255.51 - $362.11 $19.7 Million - $27.9 Million	77,100 New	77,100 $21.9 Million
Q3 2021 Nov 15, 2021	SELL	$372.64 - $458.3 $46.2 Million - $56.8 Million	-124,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$294.17 - $371.65 $11.5 Million - $14.5 Million	-39,000 Reduced 23.93%	124,000 $45.9 Million
Q1 2021 May 17, 2021	SELL	$249.67 - $299.48 $3.5 Million - $4.19 Million	-14,000 Reduced 7.91%	163,000 $47.2 Million
Q4 2020 Feb 16, 2021	SELL	$222.0 - $252.62 $4.66 Million - $5.31 Million	-21,000 Reduced 10.61%	177,000 $44.2 Million
Q3 2020 Nov 16, 2020	SELL	$175.56 - $226.45 $4.74 Million - $6.11 Million	-27,000 Reduced 12.0%	198,000 $44.8 Million
Q2 2020 Aug 14, 2020	BUY	$118.84 - $189.72 $26.7 Million - $42.7 Million	225,000 New	225,000 $39.2 Million

Others Institutions Holding CRL

# of Institutions

650

Shares Held

55M

Call Options Held

695K

Put Options Held

809K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $6.95B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lakewood Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Lakewood Capital Management, LP with notifications on news.

Account

Lakewood Capital Management, LP Charles River Laboratories International, Inc. Transaction History